BLRX
BioLineRx Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.67
−0.74%Aug 31, 2026, 11:00 UTC
BioLineRx reported its unaudited financial results for the quarter ended June 30, 2026, and provided a corporate update.
Source:Aug 28, 2026, 12:00 UTC
BioLineRx Ltd. announced a registered direct offering and concurrent private placement of 1,348,921 American Depositary Shares at $2.78 per ADS, raising approximately $3.75 million.
Source: